Although ribavirin was safe and showed a trend of decreasing viral load during therapy, the number of subjects was too small to make firm conclusions. 184 Inhaled ribavirin has been given either continuously (6 g over 18 hours) or intermittently (2 g over 2 to 3 hours three times per day).
1
—
—